Pyxis Oncology (PYXS) EBT (QoQ) (2020 - 2025)
Pyxis Oncology (PYXS) EBT (QoQ) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Pyxis Oncology | 166.54 Mn | 99.69 Mn | 8.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 22.72% |
| Sep 30, 2025 | -21.76% |
| Jun 30, 2025 | 19.89% |
| Mar 31, 2025 | 40.22% |
| Dec 31, 2024 | -77.97% |
| Sep 30, 2024 | -22.55% |
| Jun 30, 2024 | -47.47% |
| Mar 31, 2024 | 33.24% |
| Dec 31, 2023 | 26.74% |
| Sep 30, 2023 | -33.99% |
| Jun 30, 2023 | 30.15% |
| Mar 31, 2023 | 27.73% |
| Dec 31, 2022 | 13.05% |
| Sep 30, 2022 | -4.46% |
| Jun 30, 2022 | -22.71% |
| Mar 31, 2022 | 3.09% |
| Dec 31, 2021 | 29.19% |
| Sep 30, 2021 | -681.30% |
| Jun 30, 2021 | 83.39% |
| Mar 31, 2021 | -300.41% |